Clinical trial
Escitalopram as a Mood Stabilizer for Bipolar II Disorder
NCT00156325 · The University of New South Wales, Other · Completed
Key facts
| NCT number | NCT00156325 |
|---|---|
| Title | Escitalopram as a Mood Stabilizer for Bipolar II Disorder |
| Official title | A Double-Blind, Placebo-Controlled Trial of Escitalopram as a Mood Stabilizer for Bipolar II Disorder |
| Lead sponsor | The University of New South Wales, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorders |
| Intervention type | Drug |
| Interventions | Escitalopram (Lexapro) |
| Enrollment | 10 |
| Start date | Feb 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 2, 2006 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: